The CEO of Ganeden Biotech, a small company with multiple viable probiotic products but limited resources must decide which markets to invest and what intellectual property strategies best serve the immediate and longer-term business interests.

The CEO of Ganeden Biotech, a small company with multiple viable probiotic products but limited resources must decide which markets to invest and what intellectual property strategies best serve the immediate and longer-term business interests.
To maximize their effectiveness, color cases should be printed in color.
«Hide

from
Robert C. Pozen,
Dale Winger,
Matthew Ahlers
Source: Harvard Business School
29 pages.
Publication Date: Jan 16, 2010. Prod #: 310073-PDF-ENG
Ganeden Biotech, Inc. HBR case solution

[related_post themes="flat"]